Wednesday, August 5, 2015

Breaking News: AMP Rule Submitted to OMB for Final Review

BREAKING NEWS: AMP Final Rule has been sent to OMB and is expected to be released at the end of August - Just in time for IIR's MDRP Summit!

At the 20th Annual Medicaid Drug Rebate Program Summit, we've got you covered on all things AMP related across three days of the conference! Join us on September 30-October 2, 2015 for:

Wednesday, September 30th: The AMP Rule Full-Day Pre-Conference | Understand the Application, Implementation and Impact of the Final Rule
  • • Brace Yourself: The AMP Final Rule is Here! What To Do, What Not To Do & What To Do First
  • • PANEL: Deconstructing the AMP Final Rule: A Step by Step Analysis of the Key Implications of the Final Rule
  • • Identify Line Extensions & Implement Alternate Rebate Formula
  • • Clarification to the Re-definition of Bundled Sales & Its Implications
  • • How to Categorize & Calculate the 5i's
  • • Implications of the Expansion of RCP
  • • Impact of the Final Rule on Class of Trade & Innovator Products
  • • PANEL: Implementation: Constructing a Final Rule Application Checklist
Thursday, October 2nd:
  • • CMS Pharmacy Updates from John Coster, Director, Division of Pharmacy, CMS
  • • The AMP Final Rule: Operationalizing for MDRP by Alice Valder Curran, Partner, Hogan Lovells US LLP
  • • Track One: Impact of AMP on Government Pricing
  • • Track Two: Post AMP Panel Navigating the Regulatory Framework
  • • Track Three: Financial Implications of the AMP Final Rule on GP Calculations
  • • Track Four: Re-assessing GP Methodology post AMP
Friday, October 3rd:
  • • Keynote Fireside Chat with External Counsel focusing on the legal implications of the AMP Final Rule and how to remain compliant
  • • Townhall to answer all your AMP related questions moderated by John Shakow, Partner, King & Spalding  
Download the MDRP brochure for complete details.

Register now and save up to $300 off standard registration.
Be sure to use priority code: XP2058BLOG

Read the OMB Submission Here.

No comments: